Addition of interferon-α to the p53-SLP® vaccine results in increased production of interferon-γ in vaccinated colorectal cancer patients: A phase I/II clinical trial

The simultaneous ex vivo detection of low-frequency antigen-specific CD4+ and CD8+ T-cell responses using overlapping peptide pools

(2012) Satwinder Kaur Singh et al.   CANCER IMMUNOLOGY IMMUNOTHERAPY

The Anticancer Face of Interferon Alpha (IFN-Alpha): From Biology to Clinical Results, with a Focus on Melanoma

(2012) S. Pasquali et al.   CURRENT MEDICINAL CHEMISTRY

Successful treatment of metastatic melanoma by adoptive transfer of blood-derived polyclonal tumor-specific CD4+ and CD8+ T cells in combination with low-dose interferon-alpha

(2011) Els M. E. Verdegaal et al.   CANCER IMMUNOLOGY IMMUNOTHERAPY

Colorectal cancer vaccines in clinical trials

(2011) Frank M Speetjens et al.   Expert Review of Vaccines

Regulation of effector and memory T-cell functions by type I interferon

(2011) Jonathan P. Huber et al.   IMMUNOLOGY

Immunological and Clinical Effects of Vaccines Targeting p53-Overexpressing Malignancies

(2011) R. Vermeij et al.   JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY

Minimal information about T cell assays: the process of reaching the community of T cell immunologists in cancer and beyond

(2010) C. M. Britten et al.   CANCER IMMUNOLOGY IMMUNOTHERAPY

CD4+ T-Cell Help in the Tumor Milieu Is Required for Recruitment and Cytolytic Function of CD8+ T Lymphocytes

(2010) R. Bos et al.   CANCER RESEARCH

IFN-α boosts epitope cross-presentation by dendritic cells via modulation of proteasome activity

(2010) Laura Lattanzi et al.   IMMUNOBIOLOGY

Regulatory T cell frequency in patients with melanoma with different disease stage and course, and modulating effects of high-dose interferon-α 2b treatment

(2010) Paolo A Ascierto et al.   Journal of Translational Medicine

Changes in cytokine and biomarker blood levels in patients with colorectal cancer during dendritic cell-based vaccination

(2009) Stefan K. Burgdorf et al.   ACTA ONCOLOGICA

Performance of serum-supplemented and serum-free media in IFNγ Elispot Assays for human T cells

(2009) Sylvia Janetzki et al.   CANCER IMMUNOLOGY IMMUNOTHERAPY

Induction of p53-Specific Immunity by a p53 Synthetic Long Peptide Vaccine in Patients Treated for Metastatic Colorectal Cancer

(2009) F. M. Speetjens et al.   CLINICAL CANCER RESEARCH

“MIATA”—Minimal Information about T Cell Assays

(2009) Sylvia Janetzki et al.   IMMUNITY

Immunization with a P53 synthetic long peptide vaccine induces P53-specific immune responses in ovarian cancer patients, a phase II trial

(2009) Ninke Leffers et al.   INTERNATIONAL JOURNAL OF CANCER

IFN-  Enhances Peptide Vaccine-Induced CD8+ T Cell Numbers, Effector Function, and Antitumor Activity

(2009) A. G. Sikora et al.   JOURNAL OF IMMUNOLOGY

CD8+ T lymphocyte mobilization to virus-infected tissue requires CD4+ T-cell help

(2009) Yusuke Nakanishi et al.   NATURE

Vaccination against HPV-16 Oncoproteins for Vulvar Intraepithelial Neoplasia

(2009) Gemma G. Kenter et al.   NEW ENGLAND JOURNAL OF MEDICINE

Evolution of nonsurgical therapy for colorectal cancer

(2009) Rachel S Midgley et al.   Nature clinical practice. Gastroenterology & hepatology

Self-Tolerance Does Not Restrict the CD4+ T-Helper Response against the p53 Tumor Antigen

(2008) M. M. Lauwen et al.   CANCER RESEARCH

Skin reactions to human papillomavirus (HPV) 16 specific antigens intradermally injected in healthy subjects and patients with cervical neoplasia

(2008) Muriel van den Hende et al.   INTERNATIONAL JOURNAL OF CANCER